SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001831283-23-000081
Filing Date
2023-05-11
Accepted
2023-05-11 16:33:14
Documents
55
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adr-20230331.htm   iXBRL 10-Q 1028875
2 EX-31.1 exhibit311-certificationof.htm EX-31.1 16888
3 EX-31.2 exhibit312-certificationof.htm EX-31.2 16928
4 EX-32.1 exhibit321-certificationof.htm EX-32.1 5379
5 EX-32.2 exhibit322-certificationof.htm EX-32.2 5392
11 adr-20230331_g1.jpg GRAPHIC 108796
  Complete submission text file 0001831283-23-000081.txt   5293598

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adr-20230331.xsd EX-101.SCH 33322
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adr-20230331_cal.xml EX-101.CAL 53320
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adr-20230331_def.xml EX-101.DEF 141602
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adr-20230331_lab.xml EX-101.LAB 421106
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adr-20230331_pre.xml EX-101.PRE 256515
49 EXTRACTED XBRL INSTANCE DOCUMENT adr-20230331_htm.xml XML 820033
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Filer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40947 | Film No.: 23911630
SIC: 2834 Pharmaceutical Preparations